Literature DB >> 12479245

Calcium sensitivity of force in human ventricular cardiomyocytes from donor and failing hearts.

J van der Velden1, N M Boontje, Z Papp, L J Klein, F C Visser, J W de Jong, V J Owen, P B J Burton, G J M Stienen.   

Abstract

In failing human myocardium changes occur, in particular, in isoform composition and phosphorylation level of the troponin T (TnT) and troponin I (TnI) subunits of the actin filament and the myosin light chains (MLC-1 and -2), but it is unclear to what extent they influence cardiac performance. This overview concentrates on the relation between contractile function, contractile protein composition and phosphorylation levels in small biopsies from control (donor) hearts, from biopsies obtained during open heart surgery (NYHA Class I-IV) and from end-stage failing (explanted, NYHA class IV) hearts. Furthermore, attention is paid to the effect of the catalytic subunit of protein kinase A on isometric force development in single Triton-skinned human cardiomyocytes isolated from donor and end-stage failing left ventricular myocardium at different resting sarcomere lengths. A reduction in sarcomere length from 2.2 to 1.8 microm caused reductions in maximum isometric force by approximately 35% both in donor and in failing cardiomyocytes. The midpoints of the calcium sensitivity curves (pCa50) of donor and end-stage failing hearts differed markedly at all sarcomere lengths (mean delta pCa50 = 0.22). Our findings indicate that 1) TnI phosphorylation contributes to the differences in calcium sensitivity between donor and end-stage failing hearts, 2) human ventricular myocardium is heterogeneous with respect of the phosphorylation of TnT, MLC-2 and the isoform distribution of MLC-1 and MLC-2, and 3) the Frank-Starling mechanism is preserved in end-stage failing myocardium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479245     DOI: 10.1007/s003950200040

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure.

Authors:  Dániel Czuriga; Attila Tóth; Eniko T Pásztor; Agnes Balogh; Andrea Bodnár; Eniko Nizsalóczki; Vincenzo Lionetti; Fabio A Recchia; István Czuriga; István Edes; Zoltán Papp
Journal:  Basic Res Cardiol       Date:  2012-01-12       Impact factor: 17.165

3.  Calcium sensitivity and myofilament lattice structure in titin N2B KO mice.

Authors:  Eun-Jeong Lee; Joshua Nedrud; Peter Schemmel; Michael Gotthardt; Thomas C Irving; Henk L Granzier
Journal:  Arch Biochem Biophys       Date:  2012-12-14       Impact factor: 4.013

4.  Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.

Authors:  Aref Najafi; Saskia Schlossarek; Elza D van Deel; Nikki van den Heuvel; Ahmet Güçlü; Max Goebel; Diederik W D Kuster; Lucie Carrier; Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2014-07-11       Impact factor: 3.657

5.  Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background.

Authors:  Viola Kooij; Martina Saes; Kornelia Jaquet; Ruud Zaremba; D Brian Foster; Anne M Murphy; Cris Dos Remedios; Jolanda van der Velden; Ger J M Stienen
Journal:  J Mol Cell Cardiol       Date:  2010-01-15       Impact factor: 5.000

6.  Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.

Authors:  Suresh Govindan; Andrew McElligott; Saminathan Muthusamy; Nandini Nair; David Barefield; Jody L Martin; Enrique Gongora; Kenneth D Greis; Pradeep K Luther; Saul Winegrad; Kyle K Henderson; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2011-09-19       Impact factor: 5.000

7.  Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy.

Authors:  Snigdha Tripathi; Imke Schultz; Edgar Becker; Judith Montag; Bianca Borchert; Antonio Francino; Francisco Navarro-Lopez; Andreas Perrot; Cemil Özcelik; Karl-Josef Osterziel; William J McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Basic Res Cardiol       Date:  2011-07-19       Impact factor: 17.165

8.  2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.

Authors:  Farid Moussavi-Harami; Maria V Razumova; Alice W Racca; Yuanhua Cheng; April Stempien-Otero; Michael Regnier
Journal:  J Mol Cell Cardiol       Date:  2014-12-10       Impact factor: 5.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.